Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology

Korean J Radiol. May-Jun 2017;18(3):427-443. doi: 10.3348/kjr.2017.18.3.427. Epub 2017 Apr 3.


Diagnosis of hepatocellular carcinoma (HCC) with gadoxetic acid-enhanced liver magnetic resonance imaging (MRI) poses certain unique challenges beyond the scope of current guidelines. The regional heterogeneity of HCC in demographic characteristics, prevalence, surveillance, and socioeconomic status necessitates different treatment approaches, leading to variations in survival outcomes. Considering the medical practices in Korea, the Korean Society of Abdominal Radiology (KSAR) study group for liver diseases has developed expert consensus recommendations for diagnosis of HCC by gadoxetic acid-enhanced MRI with updated perspectives, using a modified Delphi method. During the 39th Scientific Assembly and Annual Meeting of KSAR (2016), consensus was reached on 12 of 16 statements. These recommendations might serve to ensure a more standardized diagnosis of HCC by gadoxetic acid-enhanced MRI.

Keywords: Consensus; Gadoxetic acid; Guidelines; Hepatocellular carcinoma; Liver; Magnetic resonance imaging.

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Carcinoma, Hepatocellular / diagnosis*
  • Carcinoma, Hepatocellular / diagnostic imaging
  • Carcinoma, Hepatocellular / pathology
  • Contrast Media / chemistry*
  • Gadolinium DTPA / chemistry*
  • Humans
  • Liver Neoplasms / diagnosis*
  • Liver Neoplasms / diagnostic imaging
  • Liver Neoplasms / pathology
  • Magnetic Resonance Imaging
  • Radiography, Abdominal
  • Republic of Korea
  • Sensitivity and Specificity
  • Societies, Scientific
  • Tomography, X-Ray Computed


  • Contrast Media
  • gadolinium ethoxybenzyl DTPA
  • Gadolinium DTPA